Para citar este trabalho use um dos padrões abaixo:
EXPRESSION, PURIFICATION AND DETERMINATION OF A SINGLE-DOMAIN ANTIBODY STRUCTURE BY NUCLEAR MAGNETIC RESONANCE
Vanessa Leite
Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro
Agora você poderia compartilhar comigo suas dúvidas, observações e parabenizações
Crie um tópicoWatch this next:
Nanobodies are single domain antibodies (sdAbs) derived from camelid heavy chain
antibody[1,2]. They are characterized by their small size (~12-16 kDa), high stability,
specificity and solubility[1-4]. Therefore, sdAbs are considered non-immunogenics due to their high similarity with variable domain sequences of heavy chains of human antibodies[5]. In this work, the expression of a nanobody (126 amino acids) from camelid – that recognizes the Fc region of IgG in rats, mice and humans – was studied under different conditions (temperature, time, culture media, strain) for determining the better conditions of expression. For the NMR analysis, the cell growth was performed in M9 medium, enriched with 13 C and 15 N, overnight, at 37ºC and using Escherichia coli host and transformation using a pet-25b vector. The protein was purified by immobilized metal affinity chromatography followed by a size-exclusion chromatography. The thermal stability of the sdAb-mrh-IgG was measured using circular dichroism. NMR spectra were acquired for the assignment of the backbone using a 600 MHz spectrometer (Bruker Avance III) with a 5 mm probe at a controlled temperature of 298K.
Lorena Mara Alexandre e Silva
Hello Vanessa. Congratulations on your work and presentation. What protein purity can you achieve with this method? Just cuirous
Elenilson de Godoy Alves Filho
Dear Vanessa, congratulations on your great work!
You divided the experimental section in 8 steps. Which of these steps were developed by you?
Best Regards!
Vanessa Leite
Hi, thank you for the compliment! I did everything described in the work, but always being supervised by someone, as I am an undergrad student and started to work in the beginning of this year (March). So I am still learning everything. Once I learnt the techinique, then I was able of doing (repeating) by myself.
Scott Prosser
Hi Vanessa,
Thanks for your talk! Are the variable domains defined by greater flexibility? Are you planning on deriving new polyclonal nanobodies to disease targets in animals or error prone PCR? And if you were going to design a bivalent Nb where would you insert your fusion protein?
best wishes
Scott Prosser
Vanessa Leite
Hello Scott! About flexibility, we do not know, we want to study it. We do not have plans on working with polyclonal nanobodies, but we have few targets in mind to built a nanobodie against, using in vitro screening. In making a bivalent quimeric protein there is no special reason to chose a fusion at the N- or C-termini of the nanobodie, since they are near in the structure.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo